✦ LIBER ✦
Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: Lessons learned from a gynecologic oncology group phase II trial of ip cisplatin and recombinant α-interferon
✍ Scribed by Maurie Markman; Jonathan S. Berek; John A. Blessing; William P. McGuire; Jeffrey Bell; Howard D. Homesley
- Book ID
- 119054219
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 675 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.